Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Prevail Therapeutics
5010
Prevail Therapeutics
Health Care
Technology
Biotechnology
Medical
Therapeutics
Prevail Therapeutics, Inc is an emerging biotech company based in New York City that is developing therapeutics for brain disorders such as Parkinson's disease.
Suggest edits
Type
B2c
Founded
2017
Raised
$75M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Bloomberg
Goldman Sachs
JPMorgan
Kickstarter
Wired
Morgan Stanley
The New York Times
Companies in the same industry
Aelix Therapeutics
NorthSea Therapeutics
Nuritas
BioTheryX
Ring Therapeutics
Seattle Genetics
Immune Design
Wilson Therapeutics
Alder Biopharmaceuticals Inc. (Nasdaq: ALDR)
Biscayne NeuroTherapeutics
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$75,000,000
Venture capital (Series A) - 2018
Adage Capital Management
RA Capital Management
OrbiMed
+6
Team Size
2
Employees
I work here
Location
New York
,
United States
Headquarters
Explore New York
$75,000,000
Venture capital (Series A)
Xconomy
,
FinSMEs
Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech
Health
Funding
Science
